Skip to main content
New product: Antibody LNP conjugation Kit

Your Partner in Animal mRNA Vaccine Development and Manufacturing

Animal mRNA Vaccine Technology Solutions

Areterna’s cutting-edge mRNA vaccine platform drives the development of innovative, cost-effective, and highly customizable veterinary vaccines.

Comprehensive Solution for Animal mRNA Vaccines

Areterna has years of experience developing veterinary mRNA vaccines with vaccine candidates, such as RV, IBRV, BVDV, PRRSV, PEDV, FMDV, PRV, FIPV, FCV, FPV, and FHV.

Vaccine Candidate Development

  • Design mRNA sequences for antigens specific for prevailing viral strains.
  • To enhance immune response, these mRNA constructs can include multiple antigens, antigen mutations, signaling peptides and co-stimulatory signals.
  • Our proprietary algorithms then optimize the entire sequence—from UTRs, CDS, to the cap and poly-A tail—ensuring maximum protein expression.

Biological Validation

Including Immunofluorescence (IF) assay, Immunoblotting (WB) assay, Flow cytometry (FCM) assay, and etc.

mRNA Synthesis / LNP Encapsulation / Analytical Development

  • We have the capability to conduct IVT synthesis in-house, along with comprehensive process development.
  • We can perform full panel QC testing on plasmid DNA, mRNA and LNP.
  • Our analytical team can develop construct-specific assays such as LC-MS based capping and tailing assay.
  • We have high-resolution Mass Spec on site as well as Zetasizer and HPLC-CAD to support LNP testing.

Pre-clinical Testing and Development

Safety and efficacy evaluation ahead of clinical advancement.

End-to-end under one roof

We offer end-to-end solutions by manufacturing mRNA vaccines and conducting pre-clinical testing under one roof.

Novel cap analogs

Our novel cap analogs bypass third-party IP, providing a strategic advantage.

Sequence design and optimization

With years of experience in mRNA sequence design and optimization, we specialize in creating highly effective mRNA constructs tailored to specific therapeutic needs.

LNP formulation development

Extensive capability and experience in LNP formulation development, enabling the creation of efficient and targeted delivery systems for various therapeutic applications.

Pre-clinical testing

We have the capability to conduct comprehensive pre-clinical testing in both cells and animal models.

BSL-3 laboratory

Our BSL-3 lab is equipped to safely handle infectious agents.

Download the animal mRNA vaccine solution Animal mRNA Vaccine Overall Solution PDF · 11.5 MB
Download the animal mRNA vaccine solution

Request a quotation

Tell us the target, the scale and the timeline you need. A scientist replies with pricing and a recommended route.